You are here: Home » Reuters » News
Business Standard

Samsung Bioepis wins EU endorsement for first Herceptin copy


By Joyce Lee and Ludwig BurgerSEOUL/FRANKFURT (Reuters) - European regulators have for the first time recommended approval of a copy of Swiss drugmaker Roche's blockbuster breast cancer drug Herceptin, made by South Korea's Samsung Bioepis Co Ltd. The European Medicines Agency said on Friday its experts had backed a copy of the drug from Samsung Bioepis, a Samsung Group unit specialising in making cheaper copies of complex biotech drugs known as biosimilars. Healthcare systems and insurers pin hopes of cost relief on the product class. With the endorsement, Bioepis' version called ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Fri, September 15 2017. 17:43 IST